在神经疾病中的乌比奎丁系统突变.
1Cell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Trends in biochemical sciences
|July 7, 2024
概括
神经元基平衡的破坏与神经系统疾病有关. 本综述涵盖了在神经发育和神经退行性疾病中理解E3结合酶和二基酶的进展.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 神经元的乌比奎丁平衡对于蛋白质平衡和细胞完整性至关重要.
- 乌比奎丁系统的干扰与神经系统疾病有关.
- 乌比奎丁系统调节神经元细胞状态转换和蛋白质清除.
研究的目的:
- 审查神经发育和神经退行性疾病中,乌比奎丁系统组件,特别是E3结合酶和duebiquitylases中的干扰.
- 突出最近在神经学上理解这些酶的进展.
- 讨论针对与ubiquitin相关疾病的治疗策略.
主要方法:
- 对该领域最近的进展进行文献综述.
- 专注于对特定酶的表征,包括E3酶和二基酶.
- 检查使用干细胞和动物模型的研究.
主要成果:
- 最近在确定关键的无素修饰酶的酶基质对方面取得了进展.
- 在利用干细胞和动物模型研究神经系统疾病中的无素系统功能障碍方面取得的进展.
- 新兴的治疗方法针对神经退行性疾病的E3合酶和二双合酶.
结论:
- 了解像E3连接酶和二连接酶这样的ubiquitin系统组件对于神经生物学至关重要.
- 最近的研究揭示了它们在神经发育和神经退行性疾病中的作用.
- 准这些酶为神经系统疾病提供了有前途的治疗途径.
更多相关视频
相关概念视频
The Proteasome
827
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
827
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522


